Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Galectin-9: An anticancer molecule for gallbladder carcinoma.

International journal of oncology - 1 Mar 2016

Tadokoro Tomoko, Morishita Asahiro, Fujihara Shintaro, Iwama Hisakazu, Niki Toshiro, Fujita Koji, Akashi Emiko, Mimura Shima, Oura Kyoko, Sakamoto Teppei, Nomura Takako, Tani Joji, Miyoshi Hisaaki, Yoneyama Hirohito, Himoto Takashi, Hirashima Mitsuomi, Masaki Tsutomu

Abstract excerpt

Gallbladder cancer (GBC) is the most common and aggressive type of biliary tract cancer. There are various histological types of GBC, and the vast majority of GBC cases are adenocarcinomas. Squamous and adenosquamous carcinomas are rare GBC subtypes that are traditionally considered to be more aggressive and to be associated with a poorer prognosis than adenocarcinoma. Galectin-9 (Gal-9), a tandem-repeat-type...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis
Share to Carcinoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Enzyme-Linked Immunosorbent Assay

Share to Galectins

Share to Gallbladder Neoplasms

Share to Mice, Inbred BALB C

Share to MicroRNAs

Share to Xenograft Model Antitumor Assays

Source

Identifiers

PMID: 26797414
DOI: 10.3892/ijo.2016.3347

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Galectin-9: An anticancer molecule for gallbladder carcinoma.PMID 26797414Read ↗

Effects of galectin-9 on apoptosis, cell cycle and autophagy in human esophageal adenocarcinoma cells.Semantic proximity Read ↗

OLFM4 depletion sensitizes gallbladder cancer cells to cisplatin through the ARL6IP1/caspase-3 axisSemantic proximity Read ↗

Establishment and characterization of a novel highly aggressive gallbladder cancer cell line, TJ-GBC2Semantic proximity Read ↗

SIRT7 levels are downregulated and are an independent prognostic factor in gallbladder cancerSemantic proximity Read ↗

miR-539-5p inhibits proliferation and invasion of gallbladder cancer cells by targeting BACH1Semantic proximity Read ↗

DGCR5 Promotes Gallbladder Cancer by Sponging MiR-3619-5p via MEK/ERK1/2 and JNK/p38 MAPK PathwaysSemantic proximity Read ↗

Identification of PEG10 and TSG101 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.Semantic proximity Read ↗

Long noncoding RNA HEGBC promotes tumorigenesis and metastasis of gallbladder cancer via forming a positive feedback loop with IL-11/STAT3 signaling pathwaySemantic proximity Read ↗

BRD9 promotes the progression of gallbladder cancer via CST1 upregulation and interaction with FOXP1 through the PI3K/AKT pathway and represents a therapeutic targetSemantic proximity Read ↗

Establishment and characterization of a cell line, EH-GB2, derived from hepatic metastasis of gallbladder cancer.Semantic proximity Read ↗

Gracillin shows potent efficacy against colorectal cancer through inhibiting the STAT3 pathwaySemantic proximity Read ↗

Long noncoding RNA MEG3 regulates LATS2 by promoting the ubiquitination of EZH2 and inhibits proliferation and invasion in gallbladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.